Ron A. A. Mathôt
← Back to Amsterdam UMC Location University of Amsterdam
Amsterdam UMC Location University of Amsterdam
Ron A. A. Mathôt works in Pharmaceutical studies and practices, Pharmacogenetics and Drug Metabolism, Antibiotics Pharmacokinetics and Efficacy, Hemophilia Treatment and Research, Platelet Disorders and Treatments. Recorded institutional associations include Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
36th International Symposium on Intensive Care and Emergency Medicine
2016 · 526 citationsLoss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
2015 · 433 citationsMetformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
2015 · 384 citationsCyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance-Associated Protein 2
2005 · 300 citationsHigh within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation
2010 · 256 citationsDeterminants of drug absorption in different ECMO circuits
2010 · 254 citationsImpact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness Analysis
1999 · 244 citationsEffect of Intravenous Paracetamol on Postoperative Morphine Requirements in Neonates and Infants Undergoing Major Noncardiac Surgery
2013 · 236 citationsAlternative drug formulations of docetaxel: a review
2006 · 211 citationsPharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
2015 · 201 citationsExplaining Variability in Mycophenolic Acid Exposure to Optimize Mycophenolate Mofetil Dosing
2006 · 191 citationsDrug interaction between St John's wort and nevirapine
2001 · 177 citationsPopulation pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the and genes
2004 · 172 citationsClinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis
2018 · 140 citationsVedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease
2019 · 132 citationsSuppression of anti‐drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease
2017 · 124 citationsEfficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial
2020 · 118 citationsPotential for improvement of docetaxel-based chemotherapy: a pharmacological review
2005 · 111 citationsMedication use during end-of-life care in a palliative care centre
2015 · 109 citationsPopulation Pharmacokinetics of Mycophenolic Acid in Renal Transplant Recipients
2005 · 100 citationsA simple quantitative method analysing amikacin, gentamicin, and vancomycin levels in human newborn plasma using ion-pair liquid chromatography/tandem mass spectrometry and its applicability to a clinical study
2014 · 89 citationsPharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients
2009 · 88 citationsYondelis® (trabectedin, ET-743): the development of an anticancer agent of marine origin
2003 · 88 citationsClinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review
2022 · 88 citationsEffect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians
2008 · 85 citations
